Acute Toxicity Profile and Compliance to Accelerated Radiotherapy Plus Carbogen and Nicotinamide for Clinical Stage T2-4 Laryngeal Cancer: Results of a Phase III Randomized Trial.

MLA

Janssens GO, et al. “Acute Toxicity Profile and Compliance to Accelerated Radiotherapy Plus Carbogen and Nicotinamide for Clinical Stage T2-4 Laryngeal Cancer: Results of a Phase III Randomized Trial.” International Journal of Radiation Oncology, Biology, Physics, vol. 82, no. 2, Feb. 2012, pp. 532–38. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2010.11.045.

APA

Janssens GO, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Pop LA, & Kaanders JH. (2012). Acute Toxicity Profile and Compliance to Accelerated Radiotherapy Plus Carbogen and Nicotinamide for Clinical Stage T2-4 Laryngeal Cancer: Results of a Phase III Randomized Trial. International Journal of Radiation Oncology, Biology, Physics, 82(2), 532–538. https://doi.org/10.1016/j.ijrobp.2010.11.045

Chicago

Janssens GO, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Pop LA, and Kaanders JH. 2012. “Acute Toxicity Profile and Compliance to Accelerated Radiotherapy Plus Carbogen and Nicotinamide for Clinical Stage T2-4 Laryngeal Cancer: Results of a Phase III Randomized Trial.” International Journal of Radiation Oncology, Biology, Physics 82 (2): 532–38. doi:10.1016/j.ijrobp.2010.11.045.